Atea Pharmaceuticals, Inc.
AVIR
$5.66
-$0.34-5.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.62% | -31.79% | -24.39% | -21.43% | -21.34% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.00% | 66.85% | 41.78% | 38.30% | 18.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -32.74% | -30.96% | -23.85% | -20.97% | -21.70% |
|
|
|||||
| Total Current Assets | -32.74% | -30.96% | -23.85% | -20.97% | -21.70% |
| Net Property, Plant & Equipment | -48.44% | -42.99% | -38.64% | -35.10% | -32.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,491.88% | 225.31% | 214.76% | 214.76% | -85.89% |
| Total Assets | -32.16% | -30.14% | -23.27% | -20.44% | -21.90% |
|
|
|||||
| Total Accounts Payable | 190.38% | -39.24% | 61.68% | -65.05% | 4.84% |
| Total Accrued Expenses | 94.80% | -14.97% | -48.68% | -30.18% | -51.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.38% | 5.32% | 5.26% | 5.46% | 5.26% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 113.86% | -19.91% | -24.42% | -47.36% | -42.54% |
|
|
|||||
| Total Current Liabilities | 113.86% | -19.91% | -24.42% | -47.36% | -42.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -79.62% | -65.86% | -56.12% | -48.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 9.58% | 9.83% | 10.12% | 10.39% |
| Total Liabilities | 54.20% | -16.19% | -19.83% | -40.65% | -35.13% |
|
|
|||||
| Common Stock & APIC | -0.63% | 0.59% | 3.06% | 6.01% | 6.93% |
| Retained Earnings | -43.48% | -44.46% | -45.45% | -53.86% | -85.98% |
| Treasury Stock & Other | -25.32% | -62.87% | 113.21% | 165.19% | 12.56% |
| Total Common Equity | -37.24% | -31.13% | -23.52% | -18.50% | -20.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.24% | -31.13% | -23.52% | -18.50% | -20.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.24% | -31.13% | -23.52% | -18.50% | -20.95% |
|
|
|||||